Clinical Trial Update: A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind trial comparing lacidipine and bendrofluazide in hypertensive patients to assess effects on platelet activation and hemorheol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Bendrofluazide (bendrofluazide)
• Lacidipine (Lacidipine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Phase 4 | Status: COMPLETED